A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike physostigmine, does not cross the blood-brain barrier.
Neostigmine is used for the symptomatic treatment of myasthenia gravis by improving muscle tone.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.